p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan

被引:0
|
作者
Lunn, RM
Zhang, YJ
Wang, LY
Chen, CJ
Lee, PH
Lee, CS
Tsai, WY
Santella, RM
机构
[1] COLUMBIA UNIV,SCH PUBL HLTH,DIV ENVIRONM HLTH SCI,NEW YORK,NY 10032
[2] COLUMBIA UNIV,SCH PUBL HLTH,DIV BIOSTAT,NEW YORK,NY 10032
[3] NATL TAIWAN UNIV,COLL PUBL HLTH,GRAD INST EPIDEMIOL,TAIPEI 10764,TAIWAN
[4] NATL TAIWAN UNIV,COLL MED,DEPT SURG,TAIPEI 10018,TAIWAN
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies have implicated aflatoxin B-1 (AFB(1)) exposure as an etiological agent in hepatocellular carcinoma (HCC) and suggested an interaction with chronic hepatitis B virus (HBV) infection, Worldwide AFB, exposure correlates with a specific mutation at codon 249 in the p53 tumor suppressor gene in liver tumors. This study investigated the roles of HBV and AFB(1) in the HCC carcinogenic pathway involving p53 mutations, In cases and controls, chronic HBV infection was assessed by serum hepatitis B surface antigen (HBsAg) and AFB(1) exposure by immunohistochemical detection of AFB(1)-DNA adduct in liver tissue. p53 protein mutations in tumor tissues of HCC cases mere identified by immunohistochemistry and DNA mutations by single-stranded conformational polymorphism and sequencing analysis, Both chronic HBsAg carrier status and liver AFB(1)-DNA adducts were significantly higher in cases than in controls with odds ratios (OR) of 8.4 and 3.9, respectively (P < 0.01), Moreover, HCC risk was greatest in individuals with both AFB(1)-DNA adducts and HBsAg, suggesting a viral-chemical interaction, Mutant p53 protein, mutations in the p53 gene, and specific codon 249 mutations were detected in 37, 29, and 13%, respectively, of the HCC cases, Most of the DNA mutations were transversions, and the only major clustering site for mutations was codon 249. AFB(1)-DNA adducts were associated with p53 protein (OR = 2.9, P = 0.054) and DNA mutations (OR = 2.9, P = 0.082) but with borderline significance, All of the codon 249 mutations (n = 12) occurred in HBsAg-seropositive carriers, resulting in an OR of 10.0 (P < 0.05), suggesting that HBV may be involved in the selection of these mutations, The ORs between HBsAg and p53 DNA and protein mutations were 2.6 (P = 0.077) and 1.8 (P > 0.05), respectively, Both p53 DNA and protein mutations were related to tumor stage, suggesting that they are late events, These studies provided further support for the role of aflatoxin exposure in HCC in Taiwan and insight into viral-chemical interactions and molecular pathogenesis.
引用
收藏
页码:3471 / 3477
页数:7
相关论文
共 50 条
  • [21] Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma
    Ni, YH
    Chang, MH
    Hsu, HY
    Tsuei, DJ
    GUT, 2003, 52 (01) : 122 - 125
  • [22] Chronic infection of hepatitis B virus and hepatocellular carcinoma in China
    Jia, J. -D.
    Guo, X.
    CHRONIC INFLAMMATION OF LIVER AND GUT, 2009, 163 : 179 - +
  • [23] Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers
    Chu, Yu-Ju
    Yang, Hwai-I
    Wu, Hui-Chen
    Liu, Jessica
    Wang, Li-Yu
    Lu, Sheng-Nan
    Lee, Mei-Hsuan
    Jen, Chin-Lan
    You, San-Lin
    Santella, Regina M.
    Chen, Chien-Jen
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (04) : 711 - 720
  • [24] TP53 R249S Mutations, Exposure to Aflatoxin, and Occurrence of Hepatocellular Carcinoma in a Cohort of Chronic Hepatitis B Virus Carriers from Qidong, China
    Szymanska, Katarzyna
    Chen, Jian-Guo
    Cui, Yan
    Gong, Yun Yun
    Turner, Paul Craig
    Villar, Stephanie
    Wild, Christopher Paul
    Parkin, Donald Maxwell
    Hainaut, Pierre
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (05) : 1638 - 1643
  • [25] Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan
    Wu, Hui-Chen
    Wang, Qiao
    Wang, Lian-Wen
    Yang, Hwai-I
    Ahsan, Habibul
    Tsai, Wei-Yann
    Wang, Li-Yu
    Chen, Shu-Yuan
    Chen, Chien-Jen
    Santella, Regina M.
    CANCER LETTERS, 2007, 252 (01) : 104 - 114
  • [26] Mutations of p53 gene in gastric carcinoma in Taiwan
    Wang, JY
    Lin, SR
    Hsieh, JS
    Hsu, CH
    Huang, YS
    Huang, TJ
    ANTICANCER RESEARCH, 2001, 21 (1B) : 513 - 520
  • [27] AFLATOXIN AND P53 ABNORMALITY IN DUCK HEPATOCELLULAR-CARCINOMA
    IMAZEKI, F
    YOKOSUKA, O
    OHTO, M
    OMATA, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (06) : 646 - 649
  • [28] Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma
    DENG ZhuoLin and MA Yun
    World Journal of Gastroenterology, 1998, (01) : 33 - 34
  • [29] Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma
    Deng, ZL
    Ma, Y
    WORLD JOURNAL OF GASTROENTEROLOGY, 1998, 4 (01) : 28 - 29
  • [30] p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection
    Kasprzak, Aldona
    Adamek, Agnieszka
    Przybyszewska, Wieslawa
    Czajka, Arkadiusz
    Olejniczak, Karolina
    Juszczyk, Jacek
    Biczysko, Wieslawa
    Zabel, Maciej
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2009, 47 (01) : 35 - 42